Pharmasure is directly involved in the marketing and distribution of specialist products used in the fertility therapeutic area i.e. Ovulation Induction and Assisted Reproductive Technology (ART) such as In-Vitro Fertilisation (IVF) and Intracytoplasmic sperm injection (ICSI).
Certain fertility treatments and Assisted Reproductive Technologies (ART), such as In-Vitro Fertilisation (IVF) require stimulation of the woman’s ovaries to produce a number of eggs. The drugs used to do this are called gonadotrophins.
There are several different brands and types of gonadotrophin.
Natural gonadotrophin purified from human urine or products produced from genetically modified Chinese hamster ovary cells in a bioreactor. All these products are effective.
For the products available in the UK the evidence concerning the different types of gonadotrophins has been assessed by the NHS National Institute for Clinical Excellence (NICE) and their findings state “Human menopausal gonadotrophin, urinary follicle-stimulating hormone and recombinant follicle-stimulating hormone are equally effective in achieving a live birth ... Consideration should be given to minimising cost when prescribing.”
Source: N.H.S. National Institute for Clinical Excellence (NICE) Fertility guidelines
“Fertility- assessment and treatment for people with fertility problems”, sections 1.6.5 and 1.6.4.1 (121K Adobe Acrobat PDF Document )
Pharmasure is the UK Distributor of the IBSA range of gonadotrophins Fostimon (Urofollitropin) and Merional (Menotrophin BP).
Institut Biochimique SA (IBSA) is a long established international pharmaceutical company based in Switzerland. You can visit the IBSA website to learn more about their products, Fostimon and Merional.
We would ask that you make your own independent judgement regarding your interaction with external web sites as these are not under Pharmasure’s control and we cannot accept responsibility for their content.
Fostimon on IBSA website Merional on IBSA website You can also check our Links section.
Useful Links